eLetters

155 e-Letters

published between 2000 and 2003

  • The debate on public place defibrillators: no longer ill informed
    Michael C Colquhoun

    Dear Editor

    Pell considers the provision of AEDs in public places an inappropriate use of health service funding because at present there is a lack of evidence both of clinical effectiveness and cost effectiveness to support this strategy.[1]

    The basis for this assertion centres on the lack of clinical trials of the use of AEDs in this situation, or a lack of comparative or baseline data in published descript...

    Show More
  • Nuclear Cardiology review
    Avijit Lahiri

    The Editor

    I thank Dr Cook for his comments regarding cardiac nomenclature used to describe nuclear images.

    I feel that his comments are justified.

    Yours Sincerely

    Avijit Lahiri

  • HFE mutation frequencies and heart disease
    Mark Worwood

    Dear Editopr

    Campbell et al. describe a study of ischaemic heart disease (IHD) and HFE gene mutations in a population where there is a high prevalence of both. They find no association between IHD and HFE genotype.

    In discussing these results they conclude that this is the largest study to date of the prevalence of the HFE gene mutations in a randomly selected mainland UK or Irish population. We a...

    Show More
  • Attitudinally correct nomenclature
    Andrew C Cook

    Dear Editor

    Drs Sabharwal and Lahiri are to be congratulated on their review. And their pictures, particularly the one chosen for the cover illustration, are exquisite. The labelling of this image, however, illustrates a fundamental problem with the way that nuclear cardiologists currently describe the heart, as we pointed out in our recent Editorial published in Heart.[1]

    The image that is described...

    Show More
  • Heart failure with preserved systolic function: is the legitimacy of the term of 'diastolic heart fa
    Stephane Arques

    Dear Editor

    I read with great interest the editorial by JE Sanderson,[1] which focuses on the current controversy about the term of "diastolic heart failure".[2-5]

    There is now evidence that in patients with symptoms and signs of heart failure without overt evidence of impaired left ventricular systolic function, delayed relaxation and/or abnormal stiffness are almost constant regardless of the severity of s...

    Show More
  • Left ventricular systolic dysfunction, ACE inhibitors and heart failure mortality
    Ali Ahmed

    Dear Editor

    We read with interest the article by Nielsen et al.[1] One of the interesting findings of that study is the rather low rates of ACE inhibitor use (16% and 8% respectively for hospitalized and community dwelling heart failure patients, and 1.7% for patients with heart disease but no heart failure). The fact that the study was done conducted between 1993 and 1996 partly explains these low rates. H...

    Show More
  • Author Reply:
    Jimenez Mazuecos J

    Dear Editor

    We sincerely appreciate the comments by Tetsuya Sato et al. concerning our report of transient apical ballooning associated with apical thrombus.[1]

    In a prior study,[2] they elegantly demonstrated, using 123I-Metaiodobenzylguanidine (MIBG), that some of these patients have extensive myocardial stunning as the result of sympathetic denervation. Reduction of MIBG accumulation, suggestive...

    Show More
  • Lights and shadows of Flecainide use in the pediatric patient
    Alessandro Giardini

    Dear Editor

    Like all medals, also flecainide has two faces. One is that of a fast and efficient antiarrhythmic drug, the other one being that of a drug with a very bad reputation.[1]

    In the October issue of Heart, Ackland et al. [2] briefly reported their experience concerning the occurrence of ventricular fibrillation in a neonate suffering from supraventricular tachycardia (SVT), likely due to the pro...

    Show More
  • Pyridostigmine in CHF: Author's Response to Dr. Nobrega
    Stuart D. Katz

    Dear Editor

    We greatly appreciate Dr Nobrega’s interest in our recent publication on the acute effects of pyridostigmine on post-exercise heart rate recovery in patients with chronic heart failure.[1]

    In accord with our published submaximal exercise data at anaerobic threshold, our more complete analysis of submaximal exercise demonstrated no differences between the effects of pyridostigmine 30 mg and pl...

    Show More
  • More about dose management
    Jack Valentin

    Dear Editor

    I was very pleased to see Professor Vano's editorial[1] and the reference to our Publication,[2] on this topic. He makes the important point that interventional cardiologists are at greater risk from radiation exposure than most other medical specialists. Of course, interventional procedures are also a potential source of quite serious radiation detriment to patients, so it is important to apply thes...

    Show More

Pages